Abiopharma

Cloudastructure Expands Multifamily Footprint With Third Deployment for Longtime Baltimore Developer

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Nakamoto Launches Intelligence 2027, a New Flagship Event for the AI Economy

Founder Group Limited Secures Second Aquaculture Contract, a US$1.4 million 1.78 MW rooftop system for a Kedah shrimp Farm

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

Clean Harbors to Acquire EnviroServe for $470 Million

Approximately 600 Registrants Draw Attention: Public- and Private-Sector Representatives Discuss the Present Status and Future of Regional School Sports Club Development

Bath & Body Works to Report Second Quarter Results on August 26, 2026

SolarWindow CEO Issues Letter to Shareholders on Commercialization Strategy and Progress